IP Verse

Elan Pharmaceuticals, Inc. opposition analysis

COMPANY ANALYSIS

Latest patents of Elan Pharmaceuticals, Inc. opposed by its competitors

Patent:
EP2645106
Grant Date:
Oct 2, 2024
Title:
Methods And Products For Evaluating An Immune Response To A Therapeutic Agent
Oppositions:
1
Patent:
EP1793855
Grant Date:
Jan 19, 2022
Title:
Prevention And Treatment Of Synucleinopathic And Amyloidogenic Disease
Oppositions:
1
Patent:
EP1991267
Grant Date:
Dec 20, 2017
Title:
Methods Of Treating Inflammatory And Autoimmune Diseases With Natalizumab
Oppositions:
1

Competitors of Elan Pharmaceuticals, Inc.

PHARMACEUTICAL WORKS POLPHARMA SA

MATHYS & SQUIRE LLP

Want to track Elan Pharmaceuticals, Inc.?

Feel free to send us a message here and we will get back to you